Aflatoxin M<sub>1</sub>

Aflatoxin M1

CAT N°: 11297

Aflatoxin M1 (AFM1) is an active metabolite of aflatoxin B1 (Item No. 11293).{61120} It induces hepatocyte hyperplasia and hepatocellular carcinoma tumor formation in rats when administered at a dose of 1 mg/animal. AFM1 (6 mg/kg) increases hepatic total lipid levels and inhibits hepatic mitochondrial and cytoplasmic protein synthesis in rats.{61121}

Territorial Availability: Available through Bertin Technologies only in France

Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.

Special Advice: Please check regulation status before ordering; additionel fees can apply.

  • Synonyms
    • (6aR,9aR)-2,3,6a,9a-tetrahydro-9a-hydroxy-4-methoxy-cyclopenta[c]furo[3′,2′:4,5]furo[2,3-h][1]benzopyran-1,11-dione
  • Correlated keywords
    • mycotoxin oxidative metabolic immunosuppressive mutagenic teratogenic carcinogenic AF-m1
  • Product Overview:
    Aflatoxin M1 (AFM1) is an active metabolite of aflatoxin B1 (Item No. 11293).{61120} It induces hepatocyte hyperplasia and hepatocellular carcinoma tumor formation in rats when administered at a dose of 1 mg/animal. AFM1 (6 mg/kg) increases hepatic total lipid levels and inhibits hepatic mitochondrial and cytoplasmic protein synthesis in rats.{61121}

We also advise you